Correction to: Safety and efficacy of nivolumab in combination with sunitinib or pazopanib in advanced or metastatic renal cell carcinoma: the CheckMate 016 study.

Amin, Asim; Plimack, Elizabeth R; Ernstoff, Marc S; Lewis, Lionel D; Bauer, Todd M; McDermott, David F; Carducci, Michael; Kollmannsberger, Christian; Rini, Brian I; Heng, Daniel Y C; Knox, Jennifer; Voss, Martin H; Spratlin, Jennifer; Berghorn, Elmer; Yang, Lingfeng; Hammers, Hans J

Amin, Asim; Plimack, Elizabeth R; Ernstoff, Marc S; Lewis, Lionel D; Bauer, Todd M; McDermott, David F; Carducci, Michael; Kollmannsberger, Christian; Rini, Brian I; Heng, Daniel Y C; Knox, Jennifer; Voss, Martin H; Spratlin, Jennifer; Berghorn, Elmer; Yang, Lingfeng; Hammers, Hans J.

Afiliação

Amin A; Immunotherapy program, Levine Cancer Institute, Carolinas HealthCare System, 1024 Morehead Medical Drive, Charlotte, NC, 28204, USA. Asim.Amin@carolinashealthcare.org.
Plimack ER; Division of Genitourinary Medical Oncology, Department of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, PA, 19111, USA.
Ernstoff MS; Division of Oncology, Department of Medicine, Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, NY, 14203, USA.
Lewis LD; Department of Medicine at The Geisel School of Medicine and The Norris Cotton Cancer Center at Dartmouth-Hitchcock Medical Center, Lebanon, NH, 03756, USA.
Bauer TM; Sarah Cannon Research Institute/Tennessee Oncology, PLLC, Nashville, TN, 37203, USA.
McDermott DF; Department of Medicine, Beth Israel Deaconess Medical Center, Dana-Farber/Harvard Cancer Center, Boston, MA, 02215, USA.
Carducci M; Department of Oncology, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, 21287, USA.
Kollmannsberger C; Division of Medical Oncology, British Columbia Cancer Agency, Vancouver, BC, V5Z 4E6, Canada.
Rini BI; Lerner College of Medicine, Department of Hematology and Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH, 44195, USA.
Heng DYC; Department of Oncology, Tom Baker Cancer Center, University of Calgary, Calgary, AB, T2N 4N2, Canada.
Knox J; Cancer Clinical Research Unit (CCRU), Princess Margaret Cancer Centre, Toronto, ON, M5G 1Z5, Canada.
Voss MH; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
Spratlin J; Department of Oncology, Cross Cancer Institute, University of Alberta, Edmonton, AB, T6G 1Z2, Canada.
Berghorn E; Oncology - Global Clinical Research, Bristol-Myers Squibb, Princeton, NJ, 08541, USA.
Yang L; Oncology - Global Clinical Research, Bristol-Myers Squibb, Princeton, NJ, 08541, USA.
Hammers HJ; Department of Internal Medicine, UT Southwestern - Kidney Cancer Program, Dallas, TX, 75390, USA.

J Immunother Cancer ; 7(1): 73, 2019 Mar 14.

Article em En | MEDLINE | ID: mdl-30871617

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Idioma: En Revista: J Immunother Cancer Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos